Drugs with this side effect as MedDRA Preferred Term
- 17-hydroxyprogesterone
- 18F-flutemetamol
- 4-AP
- 5-ASA
- Dyspnoea: very rare, postmarketing
- 5-FU
- 5-aza-2'-deoxycytidine
- 5-azacytidine
- Dyspnoea: very common, 1.96% - 29.1%
- Dyspnoea exacerbated: 3.26% - 5%
- 5-fluorocytosine
- 68Ga
- AMD3100
- Anidulafungin
- Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2
- Azarga
- BCNU
- BPTI
- Bivalirudin
- Buscopan
- CAS 76095-16-4
- CAS 76420-72-9
- CGP 19835A
- Dyspnoea: common, very common, 21%
- Cancidas
- Carfilzomib
- Colimycin M
- Dyspnoea: 10% - 16.6%
- Dyspnoea exacerbated
- EACA
- Eptifibatide
- FAMP
- FK463
- FTY720
- Fe(III
- Dyspnoea: postmarketing, 1.3% - 11%
- Forteo
- Dyspnoea: 3.6%
- Acute dyspnea: postmarketing, rare
- Gd-DTPA
- Gd-EOB-DTPA
- Ge-132
- Glat copolymer
- Goserelin
- Humalog
- ICI 182,780
- Insulin
- Dyspnoea: uncommon, 1.4% - 4.4%
- K779
- Kaluril
- L-Dmp
- LMWH
- LY146032
- Dyspnoea: postmarketing, 1.6% - 5.2%
- Leuprorelin
- Dyspnoea: postmarketing, 2% - 8%
- Lisinopril
- Lovaza
- Lutalyse
- MK-462
- Madopar
- Meropenem anhydrous
- Mersyndol
- Metrodin
- N-acetylcysteine
- Nafarelin
- Octreotide
- Optison
- Dyspnoea: postmarketing, uncommon
- Org 37462
- PCI-32765
- PGE2
- Photofrin
- Photofrin II
- Refludan
- Revasc
- Romidepsin
- S-benzoylmercaptoacetyltriglycine
- SU5416
- Stalevo 50
- Supremon
- TMC435
- Terlipressin
- TlCl
- Triptorelin
- UDCA
- VACV
- Dyspnoea: postmarketing, rare, uncommon, 7% - 38%
- Vancocine
- abacavir
- abacavir-lamivudine
- abiraterone
- acamprosate
- acebutolol
- acetaminophen
- acetylcholine
- acyclovir
- Dyspnoea: postmarketing, rare
- adenosine
- afatinib
- almotriptan
- alprazolam
- amantadine
- ambrisentan
- Dyspnoea: postmarketing, 4.21% - 5.38%
- Dyspnoea exacerbated: 1.49% - 7.69%
- amifostine
- amiloride
- amiodarone
- amlodipine
- amlodipine besylate
- amphetamine
- amphotericin B
- amsacrine
- anagrelide
- anastrozole
- anthracycline
- apomorphine
- apraclonidine
- aprepitant
- argatroban
- aripiprazole
- arsenic
- arsenic trioxide
- asenapine
- aspirin
- atazanavir
- atenolol
- atorvastatin
- atosiban
- atovaquone
- atracurium
- atropine
- axitinib
- azelastine
- azithromycin
- aztreonam
- baclofen
- Dyspnoea: rare, common, 0% - 2%
- balsalazide
- belinostat
- benazepril
- benazeprilat
- bendamustine
- benzathine penicillin
- benzocaine
- benzylpenicilloyl
- bepridil
- betahistine
- betaxolol
- Dyspnoea: postmarketing, 1.3% - 2.7%
- bexarotene
- bicalutamide
- bicarbonate
- bimatoprost
- bisoprolol
- bleomycin hydrochloride
- boceprevir
- Dyspnoea: very common, 16%
- bortezomib
- bosentan
- bosutinib
- bretylium
- brimonidine
- brinzolamide
- Dyspnoea: postmarketing, 0.2% - 2%
- bromocriptine
- Dyspnoea: postmarketing, rare
- budesonide
- bupivacaine
- buprenorphine
- bupropion
- Dyspnoea: rare, infrequent, 0% - 2%
- buspirone
- busulfan
- butorphanol
- cabazitaxel
- cabergoline
- Dyspnoea: postmarketing, 3.3%
- caffeine
- candesartan
- candesartan cilexetil
- capecitabine
- captopril
- carbamazepine
- carbidopa
- carboplatin
- carboprost
- carnitine
- carteolol
- carvedilol
- cefaclor
- cefepime
- cefoxitin
- cefpodoxime
- ceftobiprole
- cefuroxime
- cefuroxime axetil
- celecoxib
- celiprolol
- cephem
- cerivastatin
- cetirizine
- cevimeline
- chlorpromazine
- ciclesonide
- cidofovir
- Dyspnoea: postmarketing, common, 8.15% - 22.6%
- cilazapril
- cilostazol
- cinacalcet
- ciprofloxacin
- cisatracurium
- cisplatin
- citalopram
- Dyspnoea: postmarketing, infrequent, uncommon
- cladribine
- Dyspnoea: common, 5% - 7%
- clarithromycin
- Dyspnoea: postmarketing, common
- clevidipine
- clindamycin
- clodronate
- clofarabine
- clomiphene citrate
- clomipramine
- clonazepam
- clonidine
- clopidogrel
- clozapine
- Dyspnoea: postmarketing, 1%
- codeine
- colestipol
- colestyramine
- conjugated estrogens
- copolymer 1
- cosyntropin
- crizotinib
- cyanocobalamin
- cyclobenzaprine
- cyclophosphamide
- cyproterone
- cyproterone acetate
- cytarabine
- dabigatran etexilate
- dalteparin
- darifenacin
- darunavir
- dasatinib
- deferoxamine
- degarelix
- delamanid
- delavirdine
- deprenyl
- desflurane
- desloratadine
- desmopressin
- dexmedetomidine
- Dyspnoea: postmarketing, uncommon
- dexpanthenol
- dexrazoxane
- diatrizoate
- diazepam
- diclofenac
- Dyspnoea: postmarketing, rare, 0% - 2%
- dicyclomine
- diethylpropion
- diflunisal
- dihydrocodeine
- dihydroergotamine
- Dyspnoea: postmarketing, infrequent
- diltiazem
- dipyridamole
- disopyramide
- dobutamine
- docetaxel
- Dyspnoea: postmarketing, uncommon, 0.3% - 9%
- dofetilide
- dolasetron
- donepezil
- Dyspnoea: infrequent, frequent
- dopamine
- dorzolamide
- doxapram
- doxazosin
- doxepin
- doxercalciferol
- doxorubicin
- Dyspnoea: common, 1% - 23.4%
- doxycycline
- efavirenz
- eletriptan
- eltrombopag
- emtricitabine
- entacapone
- ephedrine
- eplerenone
- eprosartan
- ergonovine
- eribulin
- erlotinib
- ertapenem
- eslicarbazepine acetate
- esmolol
- esomeprazole magnesium
- estazolam
- estradiol
- estramustine
- estramustine phosphate
- etodolac
- etoposide
- etoposide phosphate
- etoricoxib
- everolimus
- Dyspnoea: common, very common, 0.5% - 20%
- exemestane
- ezetimibe
- febuxostat
- felbamate
- felodipine
- fenofibrate
- fenoldopam
- fenoprofen
- fentanyl
- Dyspnoea: postmarketing, common, 0% - 22%
- ferumoxytol
- Dyspnoea: postmarketing, 1% - 1.1%
- fexofenadine
- fidaxomicin
- finasteride
- flecainide
- fludarabine
- flumazenil
- flunisolide
- fluorescein
- fluoxetine
- fluphenazine
- flurazepam
- flurbiprofen
- fluticasone
- fluticasone furoate
- fluticasone propionate
- Dyspnoea: very rare, postmarketing, rare
- fluticasone/salmeterol
- fluvastatin
- fluvoxamine
- folate
- fondaparinux
- formoterol
- fosaprepitant
- fosaprepitant dimeglumine
- foscarnet
- fosinopril
- fosinoprilat
- fosphenytoin
- frovatriptan
- gabapentin
- Dyspnoea: infrequent
- Labored breathing
- gadobenate dimeglumine
- gadobutrol
- gadodiamide
- gadofosveset
- gadolinium
- gadopentetate
- gadoteridol
- gadoversetamide
- ganciclovir
- gatifloxacin
- gefitinib
- gemcitabine
- Dyspnoea: very common, 0% - 28%
- Acute dyspnea
- gemeprost
- gemifloxacin
- glibenclamide
- gliclazide
- glimepiride
- glipizide
- glycerol
- granisetron
- guanfacine
- haloperidol
- Dyspnoea: very rare, postmarketing
- hetastarch
- histamine
- hydralazine
- hydrochlorothiazide
- hydrocodone
- hydromorphone
- Dyspnoea: postmarketing, 3.07%
- hydroxocobalamin
- hydroxybutyrate
- hydroxyurea
- ibuprofen
- icodextrin
- ifosfamide
- iloperidone
- iloprost
- imatinib
- Dyspnoea: common, 0.5% - 21%
- imiquimod
- indacaterol
- indapamide
- indinavir
- indomethacin
- iodipamide
- iodixanol
- iohexol
- iopamidol
- iopromide
- iotrolan
- ioversol
- ioxaglate
- ioxilan
- ipratropium bromide
- irbesartan
- irbesartan-hydrochlorothiazide
- irinotecan
- Dyspnoea: postmarketing, 0% - 22%
- iron sucrose
- Dyspnoea
- Dyspnoea exacerbated
- isomannide
- isoproterenol
- isosorbide-5-mononitrate
- isradipine
- itraconazole
- Dyspnoea: postmarketing, 0% - 5%
- ivabradine
- ivermectin
- ixabepilone
- ketoprofen
- ketorolac
- ketorolac tromethamine
- labetalol
- lamivudine
- lamotrigine
- Dyspnoea: infrequent, 0% - 2%
- lanreotide
- lansoprazole
- lapatinib
- Dyspnoea: very common, 0% - 8%
- latanoprost
- leflunomide
- lenalidomide
- Dyspnoea: postmarketing, common, 4.7% - 23.5%
- Dyspnoea exacerbated
- lercanidipine
- letrozole
- Dyspnoea: uncommon, 0.819% - 18%
- leucovorin
- leuprorelin acetate
- levobunolol
- levocabastine
- levodopa/carbidopa
- levonorgestrel
- lidocaine
- linezolid
- liraglutide
- lisdexamfetamine dimesylate
- lisuride
- lithium carbonate
- lomefloxacin
- losartan
- lovastatin
- loxapine
- lubiprostone
- lurasidone
- mannitol
- medroxyprogesterone
- medroxyprogesterone acetate
- Dyspnoea: postmarketing, 0.2 - 1.0%
- mefenamic acid
- mefloquine
- megestrol
- megestrol acetate
- meloxicam
- melphalan
- memantine
- meropenem
- mesna
- metformin
- methohexital
- methotrexate
- methylene blue
- methylergometrine
- methylphenidate
- methysergide
- metipranolol
- metoclopramide
- metoprolol
- Dyspnoea: postmarketing, common
- mexiletine
- midazolam
- midodrine
- mifepristone
- milnacipran
- minocycline
- mirtazapine
- misoprostol
- mitomycin C
- mitoxantrone
- moclobemide
- modafinil
- moexiprilat
- molindone
- mometasone
- mometasone furoate
- morphine
- moxifloxacin
- mycophenolate mofetil
- mycophenolic acid
- Dyspnoea: postmarketing, 30.3% - 36.7%
- nabilone
- nabumetone
- nadolol
- nalbuphine
- naloxone
- naltrexone
- naproxen
- naratriptan
- natamycin
- nebivolol
- nedocromil sodium
- nefazodone
- nelarabine
- nelfinavir
- neostigmine
- nesiritide
- niacin
- nicardipine
- nicorandil
- nicotine
- nifedipine
- Dyspnoea: postmarketing, 1.7% - 6%
- nilotinib
- nilutamide
- nimodipine
- nisoldipine
- nitrazepam
- nitric oxide
- nitrofurantoin
- nitroglycerin
- norepinephrine
- norfloxacin
- oCRH
- ofatumumab
- ofloxacin
- olanzapine
- olopatadine
- olsalazine
- omeprazole
- ondansetron
- oxaliplatin
- Dyspnoea: common, 1% - 13%
- oxaprozin
- oxcarbazepine
- oxycodone
- oxymorphone
- oxytocin injection
- paclitaxel
- Dyspnoea: postmarketing, rare, common, 1% - 12%
- paliperidone
- palonosetron
- pamidronate
- Dyspnoea: very rare, postmarketing, uncommon, 0% - 35.1%
- pantoprazole
- parecoxib
- paricalcitol
- paroxetine
- Dyspnoea: infrequent, uncommon
- pazopanib
- pemetrexed
- penbutolol
- penicillin
- pentamidine
- pentazocine
- pentosan polysulfate
- pentostatin
- pentoxifylline
- pergolide
- perindopril
- perindopril erbumine
- perphenazine
- phencyclidine
- phenylephrine
- phenylpropanolamine
- phenytoin
- phosphate
- pilocarpine
- pimecrolimus
- pindolol
- pioglitazone
- pirfenidone
- piroxicam
- pixantrone
- polyoxyethylene
- pomalidomide
- ponatinib
- posaconazole
- potassium phosphate
- pralatrexate
- pramipexole
- Dyspnoea: postmarketing, uncommon, 1.2% - 4%
- prasugrel
- pravastatin
- Dyspnoea: postmarketing, 1.6%
- prazosin
- pregabalin
- Dyspnoea: frequent, 0% - 3%
- prochlorperazine
- progesterone
- propafenone
- Dyspnoea: postmarketing, 0% - 12.7%
- propericiazine
- propofol
- propoxyphene
- propranolol
- prostacyclin
- quetiapine
- Dyspnoea: postmarketing, frequent, 0% - 3%
- quinapril
- quinaprilat
- quinidine
- rabeprazole
- ramipril
- ramiprilat
- ranitidine
- ranolazine
- rapamycin
- rasagiline
- rasburicase
- reboxetine
- regadenoson
- Dyspnoea: postmarketing, very common, 10.7% - 29%
- remifentanil
- reserpine
- retigabine
- retinoic acid
- ribavirin
- Dyspnoea: common, very common, 5% - 25%
- rifabutin
- rifampicin
- rifapentine
- rifaximin
- riluzole
- rimantadine
- risedronate
- risperidone
- Dyspnoea: frequent, 0% - 5%
- ritonavir
- rivaroxaban
- rivastigmine
- Dyspnoea: infrequent, frequent, 2%
- rizatriptan
- rofecoxib
- ropinirole
- ropivacaine
- salbutamol
- Dyspnoea: postmarketing, 1.5%
- salmon calcitonin acetate
- saquinavir
- sertraline
- Dyspnoea: postmarketing, infrequent
- Labored breathing
- sevelamer hydrochloride
- sevoflurane
- sibutramine
- sildenafil
- Dyspnoea: 1% - 7%
- Dyspnoea exacerbated: 4% - 7%
- simvastatin
- sodium
- sodium acetate
- sodium cromoglycate
- sodium ferric gluconate
- sodium iothalamate
- sofosbuvir
- Dyspnoea: common, very common
- sorafenib
- sotalol
- Dyspnoea: postmarketing, 2% - 21%
- sparfloxacin
- sulfamethoxazole
- sulfasalazine
- sulindac
- sumatriptan
- Dyspnoea: postmarketing, infrequent, common, frequent, 1%
- sunitinib
- tacrolimus
- Dyspnoea: common, 4% - 29%
- tadalafil
- tafluprost
- tamoxifen
- tamsulosin
- Dyspnoea: postmarketing, 1.1%
- tapentadol
- technetium-99m
- teduglutide
- tegaserod
- telavancin
- telmisartan
- Dyspnoea: very rare, uncommon, common
- temazepam
- temozolomide
- Dyspnoea: common, 0.446% - 5.36%
- temsirolimus
- teniposide
- tenofovir
- tenofovir disoproxil fumarate
- tenoxicam
- terazosin
- terbutaline
- testosterone
- testosterone enanthate
- testosterone propionate
- testosterone undecanoate
- tetrabenazine
- tetraen
- tetrofosmin
- thalidomide
- Dyspnoea: postmarketing, 2.94% - 42.2%
- thiothixene
- thyroxine
- tiagabine
- tiaprofenic acid
- ticagrelor
- tigecycline
- timolol
- tinidazole
- tiopronin
- tipranavir
- tizanidine
- tobramycin
- Dyspnoea: very common, 12.4% - 33.7%
- tofacitinib
- tolcapone
- topiramate
- topotecan
- Dyspnoea: common, 1% - 22%
- toremifene
- trabectedin
- tramadol
- Dyspnoea: postmarketing, rare, uncommon
- trandolapril
- trandolaprilat
- tranexamic acid
- trans 4-cyclohexyl-L-proline
- travoprost
- trazodone
- treprostinil
- triamcinolone
- triamcinolone acetonide
- triazolam
- trifluoperazine
- trimethoprim
- trimethoprim-sulfamethoxazole
- tropisetron
- trovafloxacin
- v 1784
- Dyspnoea: postmarketing, 1% - 5%
- valdecoxib
- valganciclovir
- valproate
- valsartan
- vandetanib
- vardenafil
- varenicline
- Dyspnoea: uncommon, 1% - 2%
- venlafaxine
- Dyspnoea: uncommon, frequent
- verapamil
- vernakalant
- verteporfin
- vinflunine
- vinorelbine
- Dyspnoea: 0% - 7%
- Acute dyspnea
- vitamin K
- voriconazole
- warfarin
- zalcitabine
- zaleplon
- zanamivir
- ziconotide
- zidovudine
- Dyspnoea: postmarketing, uncommon, 5%
- zidovudine/lamivudine
- ziprasidone
- Dyspnoea: uncommon, frequent, 2%
- zoledronic acid
- Dyspnoea: uncommon, common, 1% - 20%
- zolmitriptan
- zolpidem
- zonisamide
- zopiclone
- zuclopenthixol
|
Drugs with this indication
|